Ingredalia
PrivateLast Round
Grant
Mar 2, 2021
Total Funding Raised
$851,000
Company Overview
Ingredalia operates in Healthcare & Life Sciences and is based in Milagro. Its latest recorded funding round was a Grant round in March 2021.
Ingredalia is a biotechnology company that develops and produces natural functional ingredients from vegetable by-products of the agri-food industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Circular Economy, Sustainable Materials, Waste Management
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ingredalia Comparables
Compare Ingredalia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gaia Tech AG | 87% | |
| Greencovery | 80% | |
| Kaffe Bueno | 78% |
For institutional investors. Book with your work email.
Ingredalia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 2, 2021 | ||||
| Seed | Dec 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ingredalia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Center for Technological Development and Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 4, 2026
Monthly visitors increased 789% MoM, from 37 to 329.
- Apr 15, 2025
Grew 60% QoQ, from 5 to 8 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 2, 2026
At the Alimentaria FoodTech event in Spain, Ingredalia receives FoodTech Emprende Awards recognition in the “Impact on Health and/or Well-being” category for its bioactive sulforaphane platform.
- attends_eventNov 2, 2026
Ingredalia receives recognition at the FoodTech Emprende Awards in Spain for its bioactive sulforaphane platform, which supports the formulation of functional foods and supplements.
For institutional investors. Book with your work email.
Ingredalia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ingredalia's valuation, stock price, and market status.
Is Ingredalia a public or private company?
Ingredalia is a private company.
What is the current stock price of Ingredalia?
Ingredalia is a private company, so its shares have no public market price. Caplight tracks Ingredalia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ingredalia worth (valuation)?
Valuation information for Ingredalia is not publicly available.
Can I buy Ingredalia stock?
Ingredalia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ingredalia's last funding round?
Ingredalia's most recent funding round was Grant on March 2, 2021.
Who are the main investors in Ingredalia?
Key investors in Ingredalia include Center for Technological Development and Innovation.
Will Ingredalia IPO soon?
No public IPO plans have been announced for Ingredalia.
How can I track Ingredalia secondary market activity?
Caplight tracks bids, offers, and trades in Ingredalia's shares on secondary markets.